Associate Professor of Medicine, Beth Israel Deaconess Medical Center

Gastroenterology

Daryl T. Lau is an expert in the field of Gastroenterology. Daryl T. Lau is a published doctor as well. She has 42 publications published. The latest was: Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B. She is registered with Medicare and accepts Medicare payments.

Publications

---

• Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
• A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
• Controlled Therapy Interruption Improves Host Immune Control of Chronic Hepatitis B Virus Infection in HBeAg-Positive Patients.
• Treatment cessation in noncirrhotic, e-antigen negative chronic Hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.
• Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver Disease.
• Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and HBV Genotype.
• Drug-resistance of a viral population and its individual intra-host variants during the first 48 hours of therapy.
• Lectin-reactive Anti-α-Gal in Patients with Crohn's Disease: Correlation with Clinical Phenotypes.
• IFITM1 is a tight junction protein that inhibits Hepatitis C virus entry.
• Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony.
• Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in Hepatitis C virus patients.
• A pilot study of extended duration peginterferon alfa-2a for patients with Hepatitis B e antigen-negative chronic Hepatitis B.
• Hepatitis B: the pathway to recovery through treatment.
• APRI: an easy and validated predictor of hepatic fibrosis in chronic Hepatitis C.
• A framework for management of Hepatitis C in prisons.
• Viral and therapeutic control of IFN-beta promoter stimulator 1 during Hepatitis C virus infection.
• Screening for hepatitis A and B antibodies in patients with chronic liver Disease.
• Analysis of ISG expression in chronic Hepatitis C identifies viperin as a potential antiviral effector.
• Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in Hepatitis C virus induced fibrosis.
• Tenofovir therapy for lamivudine resistance following liver transplantation.
• Antiviral therapy for treatment-naïve Hepatitis B virus patients.
• Resolution of chronic Hepatitis B-associated autoimmune neutropenia with interferon-alpha therapy.
• Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant Hepatitis B virus strains.
• Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated Hepatitis C infection.
• Virologic monitoring of Hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.
• Combination therapy with famciclovir and interferon-alpha for the treatment of chronic Hepatitis B.
• Visualizing Hepatitis C virus infections in human liver by two-photon microscopy.
• Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.
• Resolution of chronic delta Hepatitis after 12 years of interferon alfa therapy.
• Long-term follow-up of patients with chronic Hepatitis B treated with interferon alfa.
• A rapid immunochromatographic assay for Hepatitis B virus screening.
• Lamivudine for chronic delta Hepatitis.
• Long-term therapy of chronic Hepatitis B with lamivudine.
• 10-Year follow-up after interferon-alpha therapy for chronic Hepatitis C.
• Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic Hepatitis B.
• Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera.
• Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
• The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic Hepatitis C.
• Current status of antiviral therapy for Hepatitis B.
• The need for clarity in occult HBV infection.
• Subtle presentation of active primary biliary Cirrhosis in chronic hepatitis B: a case report.

Procedures Preformed

---

• Liver Biopsy

Conditions Treated

---

• Abdominal Pain
• Anemia
• Cholecystitis and Gallstones
• Cirrhosis
• View All

Doctors Specialties

---

• Gastroenterology
• Transplant Hepatology

Accepted Insurances

---

Education

---

• McGill University Faculty of Medicine

Hospital

---

• Beth Israel Deaconess Medical Center

Drug Facts

---

NPI NUMBER		1104858638
NPPES Provider LastName		LAU
NPPES Provider FirstName		DARYL
NPPES Provider ZIPCode		022155501
NPPES Provider State		MA
Specialty Description		Internal Medicine
Total Claim Count		134.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1104858638
Last Name Of The Provider	LAU
First Name Of The Provider	DARYL
View All

Similar Doctors

---

	Dr. Julia Y. McNabb-Baltar, MD This Doctor is OpenDoctor Recommended.
	Dr. Norman D. Grace, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Sanjiv Chopra, MD This Doctor is OpenDoctor Recommended.
	Dr. Judy W. Nee, MD This Doctor is OpenDoctor Recommended.
	Dr. Sagar Garud, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah N. Flier, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael Thiim, MD This Doctor is OpenDoctor Recommended.
	Dr. James M. Rabb, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark A. Peppercornmd, MD
	Dr. Tyler M. Berzin, MD This Doctor is OpenDoctor Recommended.
	Dr. Nezam H. Afdhal, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Paul C. Schroy III, MD This Doctor is OpenDoctor Recommended.
	Dr. Ansu M. Noronha, MD This Doctor is OpenDoctor Recommended.
	Dr. Hannah M. Lee, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel S. Mishkin, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog